Cargando…
Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m(2) Prior to Bariatric Surgery
FDA approved anti-obesity medications may not be cost effective for patients struggling with pre-operative weight loss prior to bariatric surgery. Metformin, a biguanide, and Topiramate, a carbonic anhydrase inhibitor, both cost effective medications, have demonstrated weight loss when used for the...
Autores principales: | Sari, Cetin, Seip, Richard L., Umashanker, Devika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947603/ https://www.ncbi.nlm.nih.gov/pubmed/33716960 http://dx.doi.org/10.3389/fendo.2021.588016 |
Ejemplares similares
-
Long-term evaluation of patients with BMI = 50kg/m(2) who underwent Bariatric Surgery
por: MEIRA, MATHEUS DUARTE, et al.
Publicado: (2023) -
Clinical Challenge: Patient With Severe Obesity BMI 46 kg/m(2)
por: Srivastava, Gitanjali, et al.
Publicado: (2019) -
One anastomosis gastric bypass as a one-stage bariatric surgical procedure in patients with BMI ≥ 50 kg/m(2)
por: Kermansaravi, Mohammad, et al.
Publicado: (2022) -
SUN-281 Topiramate-Induced BMI Reduction in an Adolescent with Severe Obesity Associated with Classical Congenital Adrenal Hyperplasia
por: Seagroves, Amy, et al.
Publicado: (2019) -
Binational cohort study comparing the management and outcomes of pregnant women with a BMI >50–59.9 kg/m(2) and those with a BMI ≥60 kg/m(2)
por: McCall, Stephen J, et al.
Publicado: (2018)